NCT00926809

H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection

Helicobacter Pylori Eradication Therapy on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection of Gastric Neoplastic Lesions: a Multicenter, Randomized, Double Blind, and Placebo Controlled Trial

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 232 (estimated)
• Sponsor: Korean College of Helicobacter and Upper Gastrointestinal Research · Academic / Other
• Sex: All
• Age: 30 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the effect of Helicobacter pylori eradication therapy on the healing of iatrogenic gastric ulcer caused by endoscopic mucosal resection of gastric neoplastic lesions and is a multicenter, randomized, double blind, and placebo controlled trial.

Conditions

• Ulcer

Interventions

Type	Name	Description
DRUG	Lansoprazole (proton pump inhibitor), amoxicillin, clarythromycin	Lansoprazole, Amoxicillin 1000 mg, Clarithromycin 500 mg
DRUG	Lansoprazole (proton pump inhibitor), placebo	Lansoprazole, Amoxicillin placebo, Clarythromycin placebo

Timeline

• Start date: 2008-09-01
• Primary completion: 2010-09-01
• Completion: 2010-12-01
• First posted: 2009-06-24
• Last updated: 2009-06-25

Locations

6 sites across 1 country: South Korea